My equity capital markets experience covers is in IPOs (including dual tracks and dual listings), placements, rights and entitlement offers, secondary offers, and convertible and corporate bond offers.

My M&A experience covers public transactions such as schemes and takeovers, as well as private treaty deals. I provide pragmatic strategic advice to clients on complex transactions in a timely manner.

I also advise on the spectrum of corporate advisory matters, including compliance, reporting and disclosure under the Corporations Act 2001 (Cth) and Australian Securities Exchange (ASX) Listing Rules, as well as directors’ duties, insider trading and insolvent trading.

My clients include listed and private companies, managed investment schemes, private equity sponsors, institutional investors, domestic and foreign entities, and lead managers and underwriters.

Clients value my cross-border experience, having worked for a top-tier law firm in New York, as well as my practical advice and innovative solutions.

I have been recognised for my transactional work by Chambers, Best Lawyers and IFLR1000. I have been a finalist in the Lawyers Weekly Australian Partner of the Year Awards.

Career highlights

• Challenger Limited – advised on the sale of it's A$3.4 billion Australian real estate business to Elanor Investors Group for consideration in the form of Elanor scrip
• Envase Technologies Inc. – advised on the US$230 million sale of Envase Technologies to WiseTech Global Limited for consideration including WiseTech scrip
• Onsite Rental Group Limited – advised on the A$635 million sale of Onsite Rental Group to an Australian subsidiary of Sime Darby Berhad
• Qualitas Limited – advised on the A$735 million IPO and ASX listing of Qualitas Limited
• Vitaco Holdings Limited – advised on the $330 million buyout and take-private of Vitaco Holdings Limited by way of a scheme of arrangement, following on from the $320 million IPO and ASX listing of Vitaco the preceding year
• CIMIC Group Limited – advised CIMIC Group Limited in connection with the A$370 million off-market takeover of MACA Limited by CIMIC subsidiary, Thiess
• Yancoal Australia Limited – advised on the A$3.2 billion equity raising to fund the acquisition of 100% of the shares in Coal & Allied
• Casa Systems, Inc. – advised on the A$160 million buyout and take-private of Netcomm Wireless Limited by way of a scheme of arrangement
• Insurance Australia Group Limited – advised on $1.5 billion placement and SPP to fund its $1.85 billion acquisition of the Australian and New Zealand insurance underwriting businesses of Wesfarmers Limited
• NobleOak Life Limited – advised on the A$163 million IPO and ASX listing of NobleOak Life Limited
• Tegel Group Holdings Limited – advised on Tegel's $551 million initial public offering (IPO) and dual listing on the ASX and New Zealand Exchange (NZX)
• Cenntro Electric Group Limited – advised on the combination by way of reverse takeover of Nasdaq-listed Naked Brand Group Limited by Cenntro Automotive Group Limited to form Cenntro Electric Group Limited
• Lloyds Banking Group – advised on the $1.55 billion sale of Lloyds' Australian asset finance business (Capital Finance Australia Limited) and corporate loan business (BOS International (Australia) Limited) to Westpac Banking Corporation
• Bellamy's Australia Limited – advised Bellamy's on the $60.4 million pro rata accelerated non renounceable entitlement offer of Bellamy’s Australia Limited
• Intermediate Capital Group – advised on the $2.5 billion IPO and ASX listing of Link Administration Holdings Limited
• Joint lead managers and underwriters – advised on the $67.5 million pro rata accelerated non renounceable entitlement offer of Xenith IP Group Limited

• Australian Life Sciences and Biotech - Key Themes and Trends

  By Daniel Scotti |October 2018

• Australian Life Sciences and Biotech - Key Themes and Trends

  By Daniel Scotti |October 2018

• Australian Life Sciences and Biotech - Key Themes and Trends

  By Daniel Scotti, Nicole Sloggett |July 2018

• MinterEllison acts on Electro Optic Systems capital raising
  

  MinterEllison advised EOS on its capital raising as the effects of COVID-19 set in

• COVID-19: ASX amends temporary extra placement capacity waiver
  

  ASX has updated the class waiver (released on 31 March) that implements temporary emergency capital raising measures to help listed entities affected by the COVID-19 pandemic. The waiver adds disclosure requirements that clarify certain matters which primarily relate to the allocation policy and process used by issuers for placements relying on the waiver.

   

• Top 10 practical tips when preparing for an IPO
  

  Is your company an IPO candidate? If so, how can you best prepare for a successful IPO? We share some top tips to maximise your chances of success.

• Australian Life Sciences and Biotech - Key themes and trends
  The Australian life sciences and biotech sector is likely to continue its resurgence over the next twelve months, with global trends driving strong M&A activity in life sciences and biotech M&A. We have identified 6 key themes for activity in this sector.
• MinterEllison advises Estia Health on its sale to Bain Capital
  

  Bain Capital has acquired 100% of the shares in Estia Health.

• Catching PIPEs in the wave of COVID-19 capital raisings
  

  With dwindling cashflows, many ASX companies have started to raise capital to shore up their balance sheets. To assist those considering PIPE, here's our everything you need to know guide.

• MinterEllison advises Onsite on $635 million sale
  

  Onsite, one of the largest business-to-business (B2B) equipment rental service providers in Australia, was sold to Sime Darby Allied Operations Pty Ltd.

• MinterEllison advises ASX-listed MCP Master Income Trust on $381 million capital raising
  

  MinterEllison has advised ASX-listed investment trust, MCP Master Income Trust (ASX:MXT), on its proposed $381 million capital raising.

• A capital idea - ASX and ASIC relax rules for COVID-19 raisings
  

  Entities needing to urgently raise funds will now have some relief, following new steps announced by ASX and ASIC to facilitate capital raisings by listed entities impacted by COVID-19. In addition, ASX has provided guidance in relation to continuous disclosure and financial reporting obligations during the pandemic.

• Weathering uncertainty: the state of Australian equity capital markets
  

  Headwinds are blowing in capital markets globally. IPO and other equity capital markets (ECM) deal volumes are down more than 70%. As capital becomes harder to access, we explore the issues that are challenging markets and businesses. What can issuers do to put themselves in the best position to raise money or see themselves through until conditions improve?

• Yancoal Australia's US$2.5bn equity raising - A landmark deal
  

  MinerEllison co-advised Yancoal Australia Limited's US$2.5 billion equity raising, which provided funding for the acquisition of 100% of the shares in Coal & Allied from wholly-owned subsidiaries of Rio Tinto Limited.